- Home
- BDRX vs KXIN Comparison
BDRX vs KXIN Comparison
Compare BDRX & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | KXIN |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United Kingdom | China |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 7.0M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDRX | KXIN |
|---|---|---|
| Price | $1.65 | $5.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 60.6K | 60.1K |
| Earning Date | 09-12-2025 | 11-26-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $0.11 |
| 52 Week High | $11.88 | $22.00 |
Technical Indicators
Market Signals| Indicator | BDRX | KXIN |
|---|---|---|
| Relative Strength Index (RSI) | 22.70 | 54.77 |
| Support Level | $1.04 | $5.30 |
| Resistance Level | $3.68 | $6.09 |
| Average True Range (ATR) | 0.20 | 0.60 |
| MACD | -0.07 | 0.09 |
| Stochastic Oscillator | 0.81 | 64.21 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.